A61K 31/166
Having the carbon of a carboxamide group directly attached to the aromatic
Official title: having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
A61K31/166 (Having the carbon of a carboxamide group directly attached to the aromatic) appears on 919 US grants and 1,588 published applications in this corpus.
Search patents in A61K- Granted patents
- 919
- Published applications
- 1,588
- Assignees
- 816
- Inventors
- 3,272
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1978 | 1 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 3 | 0 |
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 1 | 0 |
| 1987 | 1 | 0 |
| 1988 | 0 | 0 |
| 1989 | 2 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 1 | 0 |
| 1993 | 2 | 0 |
| 1994 | 1 | 0 |
| 1995 | 4 | 0 |
| 1996 | 15 | 0 |
| 1997 | 18 | 0 |
| 1998 | 19 | 0 |
| 1999 | 22 | 0 |
| 2000 | 14 | 0 |
| 2001 | 13 | 4 |
| 2002 | 18 | 18 |
| 2003 | 10 | 25 |
| 2004 | 10 | 39 |
| 2005 | 7 | 26 |
| 2006 | 11 | 29 |
| 2007 | 4 | 21 |
| 2008 | 5 | 24 |
| 2009 | 7 | 32 |
| 2010 | 9 | 49 |
| 2011 | 10 | 52 |
| 2012 | 16 | 45 |
| 2013 | 34 | 63 |
| 2014 | 37 | 88 |
| 2015 | 51 | 87 |
| 2016 | 54 | 92 |
| 2017 | 66 | 110 |
| 2018 | 51 | 94 |
| 2019 | 66 | 89 |
| 2020 | 67 | 98 |
| 2021 | 51 | 94 |
| 2022 | 51 | 94 |
| 2023 | 52 | 85 |
| 2024 | 39 | 90 |
| 2025 | 51 | 95 |
| 2026 | 20 | 45 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Prodrugs and medical uses thereof18 Aug 2026US 12,708,620 B2Convert Pharmaceuticals S.A.
- Methods of treating cancer and inhibiting TYK2 and MEK18 Aug 2026US 12,708,622 B2Washington University
- Anticancer combination therapy with N-(1-acryloyl-azetidin-3-yl)-2-((1H-indazol-3-yl)amino)methyl)-1H-imidazole-5-carboxamide inhibitor of KRAS-G12C11 Aug 2026US 12,702,658 B2Astex Therapeutics Limited
- Anti-inflammatory carboxamide derivatives21 Jul 2026US 12,686,657 B2Biomedcode Hellas SA
- Modulating permeability of the blood cerebrospinal fluid barrier14 Jul 2026US 12,678,501 B2Memorial Sloan Kettering Cancer Center
- Biphenyl compound, pharmaceutical composition, method for preparing same, and use thereof1 Oct 2026US 2026/0297017 A1Longivitron (Suzhou) Biotechnology Co., Ltd
- Methionine adenosyltransferase 2a (mat2a) inhibitor combinations and uses thereof24 Sep 2026US 2026/0284051 A1Insilico Medicine IP Limited
- Methods for producing a super central memory cd8 t cell subtype by poly(adp-ribose) polymerase (parp) inhibition and uses thereof24 Sep 2026US 2026/0286302 A1Georgetown University
- Mirdametinib treatment17 Sep 2026US 2026/0272863 A1Springworks Therapeutics, Inc.
- Methods for treating aortic valve stenosis with a hedgehog pathway inhibitor10 Sep 2026US 2026/0263396 A1The Trustees of Indiana University
Most cited
By later US patents
- Prolonged anesthesia in joints and body spaces209US 6,248,345 B1Euro-Celtique S. A. · 2001
- Prolonged anesthesia in joints and body spaces188US 6,534,081 B2Euro-Celtique S. A. · 2003
- Pharmaceutical composition containing acid addition salt of basic drug163US 6,255,502 B1Farmarc Nederland BV · 2001
- Treatment of migraine headache138US 6,077,539 APozen Inc. · 2000
- Treatment of migraine headache135US 7,030,162 B2Pozen Inc. · 2006